Acadian Asset Management LLC Can Fite Bio Pharma Ltd. Transaction History

Acadian Asset Management LLC

  • $32.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$0.94 - $1.45 $26,884 - $41,471
-28,601 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
$0.98 - $2.15 $84,481 - $185,342
-86,206 Reduced 75.09%
28,601 $36,000
Q3 2021

Nov 12, 2021
BUY
$1.65 - $2.34 $189,431 - $268,648
114,807 New
114,807 $189,000

Others Institutions Holding CANF

# of Institutions
2
Shares Held
1.1K
Call Options Held
0
Put Options Held
0
View Full List

About Can-Fite BioPharma Ltd.

CANF Quotes by TradingView
  • Ticker CANF
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,191,500
  • Market Cap $54.9M
  • Description
  • Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...
More about CANF
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email